Mainz Biomed NV Schedule 13D activist filings

Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.

David E. Lazar reports increased beneficial ownership of Quantum Cyber N.V. through conversion of preferred shares, now holding 94.3% of the class.
Investor David E. Lazar has acquired a 97.4% stake in Mainz Biomed N.V. and has been appointed as the new Chief Executive Officer.